NewBiologix
Engineered cell line technology that produces safe and effective AAV drugs for gene therapy, making treatments more affordable and accessible.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD273—409m (Dealroom.co estimates May 2023.)
Company register number CHE-291.281.035
Epalinges Canton of Vaud (HQ)